According to the TechSci Research report, “Malaria Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, Global Malaria therapeutics market is anticipated to upsurge at an impressive rate in the forecast period of 2028. Favorable government policies have a significant impact on the growth of the global Malaria therapeutics market. Governments plays a critical role in providing funding for research and development of new malaria therapeutics, as well as in ensuring the availability and affordability of these treatments. For example, if a government invests in research and development of new malaria therapeutics, it can lead to the discovery of more effective and efficient drugs. Additionally, if governments provide funding for the distribution of malaria therapeutics, it can improve access to these drugs for people living in malaria-endemic regions. Moreover, governments can also provide incentives to pharmaceutical companies to invest in the development of new malaria therapeutics. For instance, tax credits or subsidies can encourage companies to invest in research and development of new drugs. As governments continue to prioritize innovation and sustainability, it can be expected to see further growth and development in the global malaria therapeutics in the coming years.
However, some of the key challenges facing the global malaria therapeutics market include the emergence of drug-resistant strains of the malaria parasite, limited access to effective treatments in low-income countries, and the high cost of some of the newer drugs. However, ongoing research and development efforts hold promise for the development of new and more effective treatments for malaria.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on the “Global Malaria Therapeutics Market” – https://www.techsciresearch.com/report/malaria-therapeutics-market/15002.html
Global Malaria Therapeutics Market is segmented based on drug type, drug formulation, distribution channel and region. Based on drug type, the global malaria therapeutics market is segmented into Artemisinin-based combination therapy (ACT), Quinine, Chloroquine, and Others. Artemisinin-based combination therapy (ACT) is currently the dominant drug type for treating malaria, particularly for uncomplicated malaria caused by Plasmodium falciparum, which is the most deadly type of malaria parasite. This is due to the high efficacy of artemisinin and its derivatives in rapidly reducing the parasite load in the bloodstream, combined with the slower-acting partner drugs that are included in ACT regimens to prevent the development of resistance.Quinine and Chloroquine were previously widely used to treat malaria but their use has been limited due to the emergence of drug-resistant strains of the malaria parasite
Based on Drug Formulation, the global malaria therapeutics market is fragmented into Tablets, Capsules, Injectables, and others. Tablets are the dominant drug formulation for many types of medications, including those used to treat malaria. This is because tablets are easy to manufacture, transport, and store, and they are also convenient for patients to take, as they can be swallowed with water and do not require any special equipment or administration.
Major companies operating in the global malaria therapeutics market are:
- Novartis AG
- Sanofi S.A
- Pfizer Inc
- GlaxoSmithKline Plc
- Merck & Co Inc
- F. Hoffmann-La Roche AG
- Medicines for Malaria Venture
- 60° Pharmaceuticals, Inc
- Cipla Limited
- Ajanta Pharma Limited
Customers can also request for 10% free customization on this report.
“Global malaria therapeutics market is expected to grow significantly in the coming years, driven by the increasing prevalence of malaria and the development of new drugs and therapies. The market is highly competitive, with major players investing in research and development to improve their product offerings. The global effort to eradicate malaria is also expected to drive the growth of the market, as governments and international organizations fund initiatives to combat the disease. Despite the progress made in recent years, there is still a need for more effective and affordable treatments, especially in low-income countries where malaria is most prevalent. Overall, the malaria therapeutics market is poised for growth and innovation as efforts to eliminate this deadly disease continue. The growing awareness of malaria as a major public health issue, combined with the above factors, is driving the growth of the malaria therapeutics market during the forecast period,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.
“Malaria Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Drug Type (Artemisinin-based combination therapy (ACT), Quinine, Chloroquine, Others), By Drug Formulation (Tablets, Capsules, Injectables, Others), By End User (Adults, Children, Pregnant Women, Others), By Distribution Channel (Retail pharmacies, Hospitals, Online pharmacies) By Region, and Competition, has evaluated the future growth potential of global malaria therapeutics market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the global malaria therapeutics market.”
Download Free Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=15002
Related Reports:
Stable isotope labeled compounds market
Biosimilar contract manufacturing market
Fourier transform infrared spectrometer market
About TechSci Research:
TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Web: https://www.techsciresearch.com